Access cutting-edge sarcomatoid mesothelioma treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access sarcomatoid mesothelioma specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sarcomatoid mesothelioma treatment provided free
This phase II trial evaluates the safety and effectiveness of giving immunotherapy (nivolumab and ipilimumab) before surgery for controlling disease in patients with stage I-IIIa sarcomatoid mesothelioma. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving immunotherapy before surgery may be more effective at controlling disease in patients wit
Sponsor: Alliance for Clinical Trials in Oncology
Check if you qualify for this sarcomatoid mesothelioma clinical trial in Phoenix, AZ
If you're searching for sarcomatoid mesothelioma treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sarcomatoid mesothelioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.